Fundraisers / Newbridge Securities Corporation
FundraiserRegistered broker-dealer
Newbridge Securities Corporation
FINRA 104065 · placing rounds since Feb 2016
34company rounds placed
3in the last two years, last Jan 2025
$155Msold in the rounds they placed
8.5%typical commission; the median firm takes 4.9%
Named on 53 Form D filings as paid to sell the offering: 34 for operating companies, 11 for funds, 8 for real estate. 9 registered agents named.
Quarter by quarter
Company rounds they placed in each quarter, from the filings.
323Q4224Q2224Q4125Q1
What they place
- Biotechnology33%
- Oil and Gas21%
- Other Health Care15%
- Other10%
- Telecommunications8%
- Pharmaceuticals8%
- Other Technology5%
How big the rounds are
- Under $1M12
- $1M to $5M11
- $5M to $20M10
- $20M to $100M2
- $100M+0
Where the companies are
CA9PA7TX6FL6CO3NY2NJ2WA1
Rounds they placed
FiledIssuerIndustrySold
Feb 2026InvestX Series (ATR-U5 QP), a Series of InvestX Master LLCPooled Investment Fund$21M
Feb 2026InvestX Series (ATR-U5), a Series of InvestX Master LLCPooled Investment Fund$8.6M
Jan 2025Infinite Conferencing Partners, LLCAgents: Newbridge Securities CorporationTelecommunications$1.0M
Dec 2024Heritage Distilling Holding Company, Inc.Other$1.5M
Oct 2024In8bio, Inc.Biotechnology$12M
Apr 2024RenovoRx, Inc.Biotechnology$11M
Apr 2024Movano Inc.Other Health Care$24M
Dec 2023Coya Therapeutics, Inc.Biotechnology$26M
Nov 2023Infinite Conferencing Partners, LLCAgents: Newbridge Securities CorporationTelecommunications$1.4M
Oct 2023CodeLogic, Inc.Agents: Newbridge Securities CorporationOther Technology$952k
Aug 2022CodeLogic, Inc.Agents: Ceros Financial Services, Inc.Other Technology$4.0M
Apr 2022Docsnap, Inc.Other Health Care$225k
Apr 2022Lung Therapeutics, Inc.Biotechnology$10M
Mar 2022Aspargo Laboratories, Inc.Pharmaceuticals$1.5M
Feb 2022HMDmd Inc.Biotechnology$2.1M
Oct 2021BIOS SIRPant Co-Invest I QP, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
Sept 2021BIOS SIRPant Co-Invest I, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
Jul 2021BR Lake Linganore, DSTResidential$7.5M
Jun 2021Surface Ophthalmics, Inc.Agents: Newbridge Securities CorporationOther Health Care$5.8M
May 2021BR Greylyn Portfolio, DSTResidential$4.9M
Apr 2021Edison Oncology Holding CorpPharmaceuticals$250k
Dec 2020Movano Inc.Biotechnology$13M
Sept 2020BIOS ONL Co-Invest I, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
Sept 2020BIOS Actuate Co-Invest II, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
Jul 2020BIOS Fund III, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
Jul 2020BIOS Fund III QP, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
Jul 2020BIOS Fund III NT, LPAgents: Joseph Goldek, Richard Libretti, Salvatore EspositoPooled Investment Fund-
May 2020Sovereign Distressed RE Fund III, LLCCommercial-
Dec 2019ENDRA Life Sciences Inc.Agents: Lake Street Capital Markets, LLCBiotechnology$8.6M
Jul 2019Sovereign Fund II, LLCCommercial-
Dec 2018Grom Social Enterprises, Inc.Other$552k
Nov 2018ARCTRUST III, Inc.Agents: More than 5 personsREITS and Finance-
Aug 2018iSelect Qualified Purchaser Fund LLCPooled Investment Fund$3.7M
Jun 2018Passco L82 Sarasota DSTResidential$300k
Jun 2018Mewbourne Energy Partners 18-A, L.P.Oil and Gas$960k
Apr 2018BriaCell Therapeutics Corp.Biotechnology$800k
Dec 2017iSelect Innovation Fund (B) I, LLCOther$200k
Oct 2017iSelect Innovation Fund I, LLCPooled Investment Fund$65k
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.
Often on the same rounds
Other fundraisers named on the same filings: the firms they syndicate with.
Founders who worked with them
No one has said so yet.
Worked with them? Say so
A badge for their site
It shows their latest standing in the quarterly rankings and links back here.
Is this Newbridge Securities Corporation?
Claim the page to describe your work in your own words. Free.